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Abstract
Epidemiologic studies show that the cardiovascular diseases are associated with multiple 
factors such as raised serum total cholesterol, increased LDL, increased platelet aggregation, 
hypertension and smoking. In-vitro studies have confirmed the ability of some plants of Allium 
species to reduce these parameters. Therefore, we evaluated anti-platelet aggregation effect of 
some Allium species (Allium ampeloprasum, A. hirtifolium, A. haemanthoides, A. vavillovi, A. 
atroviolaceum, A. jesdianum, A. shelkovnikovii) using arachidonic acid (AA) and adenosine 
diphosphate (ADP) as platelet aggregation inducers. The screening results for methanolic 
extract of Allium species showed that the maximum effect of anti-platelet aggregation was 
related to A. atroviolaceum. This extract inhibited the in-vitro platelet aggregation induced by 
AA and ADP with IC50 values of 0.4881 (0.4826-0.4937) mg/ml and 0.4945 (0.4137-0.5911) 
mg/ml respectively. These results support the hypothesis that the dietary intake of Allium could 
be beneficial for prevention of cardiovascular diseases.
Keywords: Allium species; Alliaceae; Cardiovascular disease; Anti-platelet; Platelet 
aggregation.
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Introduction
Cardiovascular diseases are the most common 
reason of morbidity and mortality worldwide (1). 
In the western countries they account for almost 
17 million deaths; in developing countries their 
occurrence is becoming important along with 
industrialization, urbanization and changing life 
styles (2). Cardiovascular disease is associated 
with multiple factors including the increased 
ability of platelets to aggregate (3). Increased 
platelet aggregation has an important role in the 
etiology of cardiovascular diseases, which might 
be the result of multiple different mechanisms. 
In addition, in the atherosclerotic states, platelets 
adhere to the damaged vessel surface and 
aggregate themselves in response to agonists 
such as adenosine-5-diphosphate (ADP), 
thrombin, collagen and thromboxane A2 (4)
Interfering with the process of platelet 
aggregation is one of the therapeutic strategies for 
the treatment of platelet-related cardiovascular 
diseases. 
In recent years, increasing attention has been 
drawn to health benefits of food, beverages, spices 
and seasonings beyond their nutritional, tasting 
and flavoring significance. Especially, plant-
originating foodstuff such as green tea, soy bean, 
grape and their products have been recognized to 
exhibit the preventive and/or therapeutic effects 
on various diseases (5). Plant materials have 
long been used as traditional medicines for the 
treatment of a number of ailments and diseases 
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common cold (8).
Many of the biological effects of Allium 
species are related to thiosulfinate, volatile 
sulfur compounds, typical of these plants, which 
are also responsible for their pungent aroma and 
taste properties. However, these compounds are 
unstable and give rise to transformed products. 
For this reason, recent attention has been focused 
on polar compounds which are more stable for 
cooking and storage. Among these compounds, 
sapogenins, saponins, and flavonoids are the 
main classes found (8, 11).
The present research was aimed at 
investigating the effect of total extracts of 
selected group of Allium species on platelet 
aggregation induced by AA and ADP. No 
previous anti-platelet aggregation study has been 
conducted on the plants which are selected for 
the present research.
Experimental
Chemicals and Instruments
All the chemicals were purchased from 
Sigma-Aldrich Chemie Gmbh (Germany) or 
Merck (Germany) companies. The chemicals 
were of analytical grade. ADP and AA were 
purchased from Bio/Data, Corp (Germany). Anti-
platelet aggregation activity of Allium species 
extracts was determined, using APACT-4004 
aggregometer (LABiTec, Ahrensburg, 
Germany).
Plant material 
The herbs were selected based on two factors: 
Iranian traditional source of medicine and 
scientific papers. Having surveyed the flora of 
Iran and the diversity of Allium species, different 
regions were chosen as target. After collecting 
specimens, voucher specimens were confirmed 
and deposited at the herbarium (Table 1).
Extraction
Aerial parts of herbs were carefully washed 
under tap water and left to dry in controlled 
temperature (22˚C) without exposure to the 
light and moisture. They were chopped and then 
passed through sieve size 60 (25/0mm). The 
bulbous onions of plants, after collecting and 
cleaning up, were kept in nitrogen tanks in order 
(2). Scientific search for new therapeutic agents 
is strongly supported by epidemiological studies 
on medicinal plants. One would assert that it is 
feasible to make detailed studies so as to identify 
active ingredients of plant aiming to develop 
new drugs in the case the beneficial aspects are 
realized (6).
Since ancient time, a deep knowledge has 
supported the use of Allium species as food and/
or medicine. In-vitro studies have confirmed 
the ability of  some plants of Allium species 
to reduce the parameters which are taken as 
risk factors in cardiovascular diseases such as 
raised serum total cholesterol, increased LDL, 
increased platelet aggregation, hypertension 
and smoking (7). Allium is the largest and most 
important representative genus of alliaceae 
family. Alliaceae is a  family of flowering plants, 
includes about 30 genera and more than 670 
species, and is widely distributed in the northern 
hemisphere (8).
It is believed that Allium is a very variable 
and taxonomically difficult genus. The most 
recent taxonomy proposal for this genus, 
based on morphological characters and as also 
molecular data, accepted about 780 species 
belonging to fifteen subgenera and 56 sections. 
Recently, more taxa were newly described 
raising this number to more than 800 species. 
Currently, about 115 species (including more 
than 40 endemic ones) are known in the territory 
of Iran. These numbers indicate that Iran belongs 
to main center of Allium diversity in southwest 
and central Asia (9).
A. atroviolaceum has been used as foods, 
spices, and herbal remedies (10). The initial 
report of scientific research on Allium began 
in second half of the 19th century, coined by 
the work of Louis Pasteur who highlighted the 
antibacterial properties of garlic in 1858. Garlic 
has also been used for several epidemic diseases. 
In recent years, much attention has focused on 
various aspects of the pharmacological effects 
of extracts and isolated compounds from these 
plants. Several biological activities have been 
reported for Allium species such as antibacterial, 
antiviral, antiparasitic, antifungal, anti-protozoa 
and anti-diabetic, effects on the circulatory 
and cardiovascular system, antioxidant, 
anticarcinogenic effects and treatment of 
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to preserve the volatile compounds. They were 
then transferred to Freeze Dryer and dried. In 
each case, 500g of powdered plant was extracted 
with 1500ml methanol by maceration method. 
Extraction was conducted for 48h and repeated 
four times under stirring at 80r/ minute rate. 
The extracts were then filtered and concentrated 
under vacuum at 40˚C using a rotary evaporator.
Preparation of samples for Platelet 
aggregation test 
The extracts were dissolved in DMSO at the 
concentration of 250mg/ml. In fact, the initial 
stock solution contained the maximum amount 
of the extract which was soluble in 1 ml. The 
entire stock was passed through a Syringe Filter 
PVDF 0.22µm which is compatible with the 
organic solvent DMSO. One microliter of the 
solution of extract in DMSO was added to 200µl 
of plasma so that, the final concentrations of 
extracts in plasma were from 1.25 to 0.3125mg/
ml. Inspecting the filtrate for particles showed 
that despite the filtration, some particulate 
matters formed in the solution a few minutes 
after filtration. Therefore, in order to overcome 
the problem, polyvinyl alcohol (PVA) was added 
to the solutions at the concentration of 1% prior 
to the filtration process. No particulate matter 
formed in the solution even after one hour of 
the addition of PVA. A blank mixture of DMSO 
and PVA in plasma showed no effect on platelet 
aggregation process (Figure 1). Therefore a series 
of solutions of the plant extract was prepared in 
DMSO/PVA 1%.
Blood collection 
Blood was obtained from healthy volunteers 
who did not take any medication for 14 days 
Scientific Name Part of herb Place of collection Voucher number Place of specimen deposition
Allium ampeloprasum L. Aerial part Mount Rig, lordegan- Shahr-e-kord 8012 1
Allium hirtifolium  Boiss. Bulb Mount Sabz-e-koh,  Shahr-e-kord 8010 1
Allium hirtifolium Boiss. Aerial part Mount Sabz-e-koh,  Shahr-e-kord 8010 1
Allium haemanthoides Boiss. & Reut. Aerial part Izeh, Ahvaz 8008 1
Allium vavillovi M.Pop & Vved. Aerial part Shahr-e-reza, Isfehan 8009 1
Allium atroviolaceum Boiss Aerial part Mount Rig, lordegan- Shahr-e-kord 8013 1
Allium jesdianum Boiss. & Buhse Bulb Tezerjan-Yazd 2252 2
Allium  shelkovnikovii Grossh. Bulb Tabriz 3033 3
Table 1. Scientific names, part of herb, place of collection, voucher number and place of deposition of plants which have been used in 
the present study.
1Herbarium of department of Pharmacognosy of faculty of Pharmacy of Shahid Beheshti University of medical sciences 
2 Herbarium of Yazd Research Center for Agriculture and Natural Resources
3 Herbarium of East Azarbaijan Research Center for Agriculture and Natural Resources
Figure 1. Aggregograms obtained for DMSO (a), DMSO/PVA 1% (b, c, d).
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and were fasting overnight prior to the study. 
Blood was collected in falcon tube containing 
0.1 volume of 2.2% sodium citrate. Platelet rich 
plasma (PRP) was prepared by the centrifugation 
of citrated blood at 100g for 10min. The residual 
blood was centrifuged at speed of 1500g for 15 
min to give platelet poor plasma (PPP). Platelets 
were counted under microscope and the platelet 
count was adjusted to (250 ± 25) ×109/L. 
Supernatant PRP was diluted with PPP.
Platelet aggregation studies
Platelet aggregation responses were 
monitored with a turbidometric method using an 
optical aggregometer. Platelet aggregation was 
expressed as an increase in light transmission. 
The levels of transmission were calibrated by 
PPP and PRP. Aliquots of 200μl of PRP were 
distributed in the test cuvettes and placed in 
incubation chamber of aggregometer at 37°C. 
Platelet aggregation was measured using PRP 
after activation by the addition of ADP or AA 
according to Born method (12). 1µl of the 
prepared solution of methanolic extracts in 
DMSO/PVA was added to the PRP, 5 min prior 
to the activation with ADP or AA. The extent 
of aggregation was quantified by determining 
the maximum height of the curve. The platelet 
aggregation inhibitory activity was expressed as 
percent inhibition compared with that measured 
for the vehicle (DMSO/PVA1%) alone (13). 
Finally, percent inhibition for extract is calculated 
according to the following formula:
100 × ((1 - (D/S)) = percent inhibition
Aggregation in the sample = D
Aggregation in the presence of solvent 
(DMSO/PVA1%) = S
Statistical analysis
The anti-aggregation value of each extract 
was expressed as either % inhibition or IC50 
values (the concentration of the compound 
causing 50% inhibitory effects). The IC50 values 
were estimated by non linear curve-fitting and 
presented as their respective 95% confidence 
limits. One-way analysis of variance (ANOVA) 
followed by Tukey’s post test was used to assess 
the significant differences (p < 0.05) between 
the responses caused by the extracts. All the 
statistical analyses were accomplished using 
the computer software GraphPad Prism 3.02 for 
Windows (GraphPad Software, USA).
Results and discussion
Aerial parts of the plant species Allium were 
extracted by maceration method with methanol. 
After concentrating under the vacuum at 40˚C 
with rotary evaporator, the yield of extraction 
was calculated (Table 2). The highest % yield is 
related to leaves of A. atroviolaceum. While the 
bulb of A. jesdianum Boiss. & Buhse has lowest 
% yield of extraction.
PVA (polyvinyl alcohol) was used to prevent 
the formation of particulate matters in the plant 
extract solutions in DMSO. Investigating the 
effect of blank DMSO/PVA solution on platelet 
aggregation confirmed that the presence of PVA 
at 1% concentration has no effect on platelet 
behavior. To the best of our knowledge, this 
is the first report for the application of PVA in 
determining anti-platelet aggregation activity of 
solutions which tend to form insoluble particles 
in DMSO.
Anti-platelet aggregation activity is not 
uncommon from plants extracts. Gady’s et 
al (2009) have reported a significant platelet 
aggregation inhibitory activity from the total 
aqueous extract of leaves of parsley (IC50: 5.6mg/
ml) against the aggregation induced by ADP 
(14). Although there are citations of antiplatelet 
aggregation activity of some Allium species (15-
17), there are no previous reports, at least to our 
knowledge, on the activity of the genus on in-
vitro platelet aggregation induced by AA and 
ADP. Allium extracts which were added to PRP 
5min prior to their stimulation by AA (1.35mM) 
and ADP (5µM) inhibited platelets aggregation 
Yield of extraction Scientific name
7.3% Allium  ampeloprasum L.
5% Allium hirtifolium Boiss.
3% Allium hirtifolium Boiss.
6% Allium haemanthoides Boiss. & Reut
7% Allium vavillovi M.Pop & Vved.
8% Allium atroviolaceum Boiss.
2.5% Allium jesdianum Boiss. & Buhse
2.7% Allium shelkovnikovii Grossh.
Table 2. Yields of methanolic extraction by maceration method.
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jesdianum and A. shelkovnikovii) were found 
to have satisfactory inhibitory effect on platelet 
aggregation against AA. The IC50 (AA) values 
for A. hirtifolium (Bulb), A. hirtifolium (Aerial 
part), A. atroviolaceum, A. jesdianum and A. 
shelkovnikovii extracts are presented in Table 
3. According to Tukey’s multiple comparison 
test, the mentioned extracts showed significant 
differences in their IC50 values (p < 0.05) 
except A. shelkovnikovii verses A. hirtifolium 
(Bulb). The IC50 values of extracts increased 
in the following order: A. atroviolaceum < A. 
jesdianum < A. hirtifolium (Aerial part) < A. 
shelkovnikovii ≤ A. hirtifolium (Bulb). Based on 
the data obtained the A. atroviolaceum extract 
with IC50 value of 0.4881 mg/ml (0.4826-0.4937) 
has maximum antiplatelet aggregation capacity 
induced by ADP.
However, A. hirtifolium (Aerial part) extract 
produced a weak activity on in-vitro platelet 
aggregation induced by ADP (5μM) while A. 
ampeloprasum (Aerial part), A. haemanthoides 
(Aerial part) and A. vavillovi (Aerial part) 
extracts caused a weak effect on in-vitro platelet 
aggregation induced by AA (1.35mM). They 
did not achieve ≥ 50% inhibition of platelet 
aggregation activity. The maximum inhibition 
(%) was 41.32% ± 3.15 for A. hirtifolium (Aerial 
part), 37.01% ± 4.34 for A. ampeloprasum (Aerial 
part), 31.85% ± 5.21 for A. haemanthoides 
(Aerial part) and 41% ± 3.67 for A. vavillovi 
(Aerial part) at maximum concentration of 1.25 
mg/ml.
Blood platelets, beside their physiological 
in a concentration-dependent manner. The 
effects of extracts at different concentrations 
were measured and compared to each other. The 
results were expressed as IC50 values with their 
respective 95% confidence limits (Table 3).
In the present study, among the eight Allium 
extracts tested, seven extracts (A. ampeloprasum, 
A. hirtifolium [Bulb], A. haemanthoides, A. 
vavillovi, A. atroviolaceum, A. jesdianum and A. 
shelkovnikovii) were found to possess satisfactory 
inhibitory effect on platelet aggregation against 
ADP. The IC50 values for A. ampeloprasum, 
A. hirtifolium (Bulb), A. haemanthoides, A. 
vavillovi, A. atroviolaceum, A. jesdianum and 
A. shelkovnikovii extracts are presented in Table 
3. According to Tukey’s multiple comparison 
test, the mentioned extracts showed significant 
differences in their IC50 values (p < 0.05) except 
A. jesdianum verses A. haemanthoides, A. 
jesdianum vs A. shelkovnikovii, A. haemanthoides 
vs A. ampeloprasum, A. haemanthoides vs 
A. shelkovnikovii and A. ampeloprasum vs A. 
shelkovnikovii . The IC50 (ADP) values of extracts 
increased in the following order: A. atroviolaceum 
< A. vavillovi < A. jesdianum ≤ A. shelkovnikovii 
≤ A. ampeloprasum ≤ A. haemanthoides ≤ A. 
hirtifolium (Bulb). Based on the data obtained, 
the A. atroviolaceum extract with IC50 value of 
0.4945 (0.4137-0.5911) has maximum potency 
for inhibition of platelet aggregation induced by 
ADP.
Furthermore, among the eight Allium extracts 
tested, five extracts (A. hirtifolium [Bulb], A. 
hirtifolium [Aerial part], A. atroviolaceum, A. 
Plant species IC50(ADP) (mg/ml)+ IC50(AA) (mg/ml)+
A. ampeloprasum (Aerial part) 0.6982 (0.6089-0.8005)cd -
A. hirtifolium (Bulb) 0.8693 (0.7806-0.9681)e 0.8765 (0.8765-0.8766)d
A. hirtifolium (Aerial part) - 0.6843 (0.5665-0.8266)c
A. haemanthoides (Aerial part) 0.7366 (0.6856-0.7913)d -
A. vavillovi (Aerial part) 0.5524 (0.4997-0.5525)b -
A. atroviolaceum (Aerial part) 0.4945 (0.4137-0.5911)a 0.4881 (0.4826-0.4937)a
A. jesdianum (Bulb) 0.6607 (0.5140-0.8491)c 0.5228 (0.5057-0.5404)b
A. shelkovnikovii (Bulb) 0.6905 (0.4448-1.072)c 0.8365 (0.7495-0.9336)d
Table 3. Effect of methanolic extract of Allium species on in-vitro platelet aggregation induced by AA (1.35mM) and ADP (5μM).
*Note: The IC50 value of the positive control, quercetin, was measured as 0.1197 (0.1047-0.1362) mg/ml against AA and 0.1982 (0.1405-
0.2131) mg/ml against ADP.
+ The IC50 values are presented with their respective 95% confidence limits (n = 3)
‡Letters (a-e) denote homogenous subsets at p < 0.05 (Tukey’s post test).
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function, play a critical role in the pathogenesis 
of some cardiovascular diseases such as 
arterial hypertension, atherosclerosis and 
subsequent ischemic events. This study 
highlights Allium anti-platelet properties. This 
finding is in agreement with other previous 
published data (15-17). We have shown that 
in-vitro, methanolic Allium extract inhibited 
in concentration-dependent manner, AA and 
ADP-induced platelet aggregations. Our results 
indicate that the maximum effect of anti-platelet 
aggregation was related to A. atroviolaceum. 
Therefore, A. atroviolaceum with an IC50 value 
0.4881 (0.4826-0.4937) mg/ml inhibits platelet 
aggregation induced by AA and to a lesser extent 
aggregation induced by ADP (p value < 0.05). 
However Hiyasat et al (2009) have reported 
that A. ursinum and A. sativum inhibit platelet 
aggregation induced via the ADP pathway and 
to a lesser extent the aggregation induced by 
epinephrine, whereas Aggregate Resources 
Act (ARA)-, collagen- and A23187-induced 
aggregations were not affected (15).
Medicinal plants are potential sources of 
lead compounds which can be used for further 
study and optimization as new drugs (18). 
Phytochemical analysis of Allium species has 
revealed the presence of polar compounds such 
as sulfur compounds and flavonoids, saponins 
and sapogenins (8). It is very unlikely that only 
one compound in the extract has been responsible 
for the observed anti platelet activity and it is 
more likely that a combination of compounds 
are involved in the exerted inhibitory effect, such 
as polyphenolic compounds that could prevent 
platelet functions. Additionally numerous 
in-vitro and in-vivo studies have shown that 
flavonoids inhibited primary homeostasis 
and many pathways associated with platelet 
activation and aggregation (14).
In conclusion, the present work demonstrated 
that Allium extracts could inhibit in-vitro platelet 
aggregation induced by AA and ADP. These 
results support the hypothesis that the dietary 
intake of Allium may be beneficial in normalizing 
platelet hyperactivation, in nutritional prevention 
of cardiovascular diseases which are potentially 
interesting in the development of new prevention 
strategies. Therefore, they are good candidates 
for further in-vitro and in-vivo studies to 
find potential lead compound for antiplatelet 
aggregation.
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